Re-evaluating the evidence for fecal microbiota transplantation “super-donors” in inflammatory bowel disease
View ORCID ProfileScott W. Olesen, Ylaine Gerardin
doi: https://doi.org/10.1101/19011635
Scott W. Olesen
1OpenBiome, Cambridge, MA
2Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA
PhDYlaine Gerardin
3Finch Therapeutics, Somerville, MA
PhDData Availability
Computer code and underlying data to reproduce the results are online at https://www.github.com/openbiome/donor-effects.
Posted November 12, 2019.
Re-evaluating the evidence for fecal microbiota transplantation “super-donors” in inflammatory bowel disease
Scott W. Olesen, Ylaine Gerardin
medRxiv 19011635; doi: https://doi.org/10.1101/19011635
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (680)
- Anesthesia (182)
- Cardiovascular Medicine (2692)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12326)
- Forensic Medicine (10)
- Gastroenterology (771)
- Genetic and Genomic Medicine (4164)
- Geriatric Medicine (392)
- Health Economics (688)
- Health Informatics (2702)
- Health Policy (1010)
- Hematology (366)
- HIV/AIDS (864)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3947)
- Nursing (214)
- Nutrition (587)
- Oncology (2076)
- Ophthalmology (596)
- Orthopedics (244)
- Otolaryngology (308)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (474)
- Pediatrics (1133)
- Primary Care Research (462)
- Public and Global Health (6590)
- Radiology and Imaging (1428)
- Respiratory Medicine (877)
- Rheumatology (415)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (55)
- Transplantation (191)
- Urology (170)